A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C-Modified Vaccinia Ankara Virus Vaccine Candidate in Indian VolunteersVadakkuppatu Devasenapathi Ramanathan, Patricia Fast, Jayashri Mahalingam et al.|AIDS Research and Human Retroviruses|2009Cited by 59